These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 7933610

  • 21. [Intracavernous injection of lipo prostaglandin E1 for the diagnosis of impotence: a comparative study with prostaglandin E1-CD].
    Yajima M, Baba K, Minagawa N, Kohno S, Haraguchi C, Iwamoto T, Osada T.
    Hinyokika Kiyo; 1993 Mar; 39(3):289-92. PubMed ID: 8506803
    [Abstract] [Full Text] [Related]

  • 22. Therapeutic effect of anti-TNF-alpha antibodies in an experimental model of anti-neutrophil cytoplasm antibody-associated systemic vasculitis.
    Little MA, Bhangal G, Smyth CL, Nakada MT, Cook HT, Nourshargh S, Pusey CD.
    J Am Soc Nephrol; 2006 Jan; 17(1):160-9. PubMed ID: 16306166
    [Abstract] [Full Text] [Related]

  • 23. Monoclonal-antibody therapy in systemic vasculitis.
    Mathieson PW, Cobbold SP, Hale G, Clark MR, Oliveira DB, Lockwood CM, Waldmann H.
    N Engl J Med; 1990 Jul 26; 323(4):250-4. PubMed ID: 2366834
    [No Abstract] [Full Text] [Related]

  • 24. [Lipo prostaglandin E1 administration in the acute stage following subarachnoid hemorrhage].
    Korosue K, Kondoh T, Ishikawa A, Suzuki H, Nagao T, Tamaki N, Matsumoto S.
    No Shinkei Geka; 1988 Jul 26; 16(5 Suppl):509-15. PubMed ID: 3399005
    [Abstract] [Full Text] [Related]

  • 25. Beneficial effects of intravenous administration of lipo-prostaglandin E1 on the ischemic gastric tube in pigs.
    Tobari S, Ikeda Y, Takami H.
    J Surg Res; 2005 Nov 26; 129(1):79-84. PubMed ID: 16087193
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Clinical effect of treatment with lipo-prostaglandin E1 on the patients with chronic glomerulonephritis].
    Zhong WQ, Liu GX, Yang YM, Cai X, Huang ZL.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 May 26; 16(5):292-4. PubMed ID: 15132795
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Update on therapeutic monoclonal antibodies.
    Bussel JB, Giulino L, Lee S, Patel VL, Sandborg C, Stiehm ER.
    Curr Probl Pediatr Adolesc Health Care; 2007 Apr 26; 37(4):118-35. PubMed ID: 17434008
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. New strategies in the treatment of systemic vasculitis.
    Jayne DR, Lockwood CM.
    Ann Med Interne (Paris); 1994 Apr 26; 145(8):595-600. PubMed ID: 7710186
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Randomized control trial of lipo-prostaglandin E1 in patients with acute liver injury induced by lipiodol-targeted chemotherapy.
    Ikegami T, Matsuzaki Y, Kurusu J, Yoshiga S, Saito Y, Chiba T, Abei M, Shoda J, Tanaka N, Osuga T.
    Clin Pharmacol Ther; 1995 May 26; 57(5):582-9. PubMed ID: 7768081
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.